OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL — image 1 of 3

Product details

OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL

Catalog number BNC402400-100

Price for BNC402400-100

Size / count 1x 100 µL

About this product

Olig2, a basic helix-loop-helix transcription factor, is involved in oligodendroglial specification. Olig2 expression has been reported in most glial tumors, such as oligodendrogliomas and astrocytomas. Although more than half of glioblastomas are positive for Olig2, expression is very weak in terms of both percentage of labeled cells and intensity. No Olig2 expression has been found in the non-glial tumors including neuro-epithelial tumors, ependymomas, sub-ependymomas, medulloblastomas, and non-neuroepithelial tumors, such as CNS lymphomas, meningiomas, schwannomas, atypical teratoid / rhabdoid tumor, and haemangioblastomas. Compared to the strong staining seen in glioma samples, a weak expression is observed in non-tumoral brain tissue (gliosis) .Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNC402400-100
Size / count: 1x 100 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: Basic helix loop helix protein class B1 (bHLHB1) ; basic helix-loop-helix protein 19 (bHLHe19) ; OLIG2; Oligodendrocyte lineage transcription factor 2; Oligodendrocyte specific bHLH transcription factor 2; Oligodendrocyte transcription factor 2; Protein kinase C-binding protein 2 (PRKCBP2) ; RACK17
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: OLIG2
Gene ID: 10215
NCBI Gene ID: 176977
UniProt: Q13516
Swiss Prot: Q13516
Host: Mouse
Species Reactivity: Human
Reactivity: OLIG2
Immunogen: Recombinant fragment of human OLIG2 protein (around aa 1-141) (exact sequence is proprietary)
Target Antigen: OLIG2
Clonality: Monoclonal
Clone: OLIG2/2400
Type: Primary
Source: Animal
Origin: Animal
Applications: IHC, FFPE (verified)
Field of Research: Cancer, Neuroscience, Transcription factors
Positive Control: THP-1 cells. Astrocytoma
Stability: 2 years
Concentration: 0.1 mg/mL
Buffer: PBS, 0.1% BSA, 0.05% azide
Molecular Weight: 30-40 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Notes: Protect from light
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG1, kappa
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: 0.05% sodium azide (CAS 26628-22-8)
Conjugate: CF640R

Frequently Asked Questions

What is the catalog number for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL?

The catalog number for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL is BNC402400-100.

What sizes are available for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL?

OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL is available in the following size(s): 1x 100 µL.

Is OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL in stock?

OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL?

OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL?

Estimated delivery time for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL?

The safety data sheet for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF640R conjugate, 0.1mg/mL used for?

Do you provide a Certificate of Analysis (CoA) for this product?

A Certificate of Analysis is available for most products upon request. Contact our support team with the lot number to obtain the relevant CoA.

Is this product suitable for live cell imaging?

Suitability for live cell imaging depends on the specific reagent and conjugate used. Check the datasheet for imaging-specific validation, or contact us for guidance.

Is this product covered by a money-back guarantee?

Yes, we guarantee a full refund or store credit if this product arrives damaged beyond usability, or has a genuine performance issue under proper usage and storage, provided you report it immediately with evidence. Claims after the expiration date or due to improper storage after receipt are excluded.